We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Face Fee Increase From MHRA Next Year
Drugmakers Face Fee Increase From MHRA Next Year
November 16, 2009
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has proposed a 1 percent increase in fees on drugmakers for regulatory activities
in the UK starting in April. Includes the full text of MHRA Regulatory
Fees Proposal.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor